Free Trial

ImmuCell (ICCC) News Today

ImmuCell logo
$6.88 +0.23 (+3.46%)
Closing price 03:59 PM Eastern
Extended Trading
$6.46 -0.42 (-6.10%)
As of 05:14 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ICCC Latest News

ImmuCell Corporation stock logo
ImmuCell Co. (NASDAQ:ICCC) Short Interest Down 51.3% in May
ImmuCell Co. (NASDAQ:ICCC - Get Free Report) was the target of a large drop in short interest in May. As of May 31st, there was short interest totalling 5,700 shares, a drop of 51.3% from the May 15th total of 11,700 shares. Currently, 0.1% of the company's stock are short sold. Based on an average daily volume of 25,300 shares, the days-to-cover ratio is presently 0.2 days.
ImmuCell Corporation stock logo
ImmuCell Co. (NASDAQ:ICCC) Short Interest Update
ImmuCell Co. (NASDAQ:ICCC - Get Free Report) saw a large growth in short interest during the month of May. As of May 15th, there was short interest totalling 11,700 shares, a growth of 82.8% from the April 30th total of 6,400 shares. Based on an average daily trading volume, of 23,800 shares, the days-to-cover ratio is presently 0.5 days. Currently, 0.2% of the company's shares are sold short.
ImmuCell Corporation stock logo
ImmuCell (NASDAQ:ICCC) Shares Pass Above 200 Day Moving Average - Here's What Happened
ImmuCell (NASDAQ:ICCC) Shares Pass Above 200 Day Moving Average - Time to Sell?
Top Stock Reports for Netflix, SAP & Shell
Immucell reports preliminary Q1 revenue $8.1M vs. $7.3M last year
Immucell appoints Timothy Fiori as CFO
ImmuCell Names Timothy Fiori Finance Chief
ImmuCell Hires Chief Financial Officer
Immucell initiates Investigational Product use of Re-Tain
Immucell sees FY25 revenue $111M-$113M, consensus $107.93M
Immucell reports preliminary Q4 sales $7.8M vs. $5.1M last year
ImmuCell Reports Strong Sales Growth in Q3 2024
ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 2024
ImmuCell Corporation (ICCC)
Get ImmuCell News Delivered to You Automatically

Sign up to receive the latest news and ratings for ICCC and its competitors with MarketBeat's FREE daily newsletter.

ICCC Media Mentions By Week

ICCC Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ICCC
News Sentiment

0.00

0.62

Average
Medical
News Sentiment

ICCC News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ICCC Articles
This Week

1

1

ICCC Articles
Average Week

Get ImmuCell News Delivered to You Automatically

Sign up to receive the latest news and ratings for ICCC and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:ICCC) was last updated on 6/24/2025 by MarketBeat.com Staff
From Our Partners